{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:59:22Z","timestamp":1794049162826,"version":"4.8.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>Atypical teratoid\/rhabdoid tumor (AT\/RT) is a malignant central nervous system tumor predominantly affecting infants. Mutations of <jats:italic toggle=\"yes\">SMARCB1<\/jats:italic> or (rarely) <jats:italic toggle=\"yes\">SMARCA4<\/jats:italic> causing loss of nuclear SMARCB1 or SMARCA4 protein expression are characteristic features, but further recurrent genetic alterations are lacking. Most AT\/RTs occur de novo, but secondary AT\/RTs arising from other central nervous system tumors have been reported. Malignant gliomas, IDH wild-type, arising in patients with Li-Fraumeni syndrome typically show somatic mutations of <jats:italic toggle=\"yes\">TP53<\/jats:italic> as well as complex copy number alterations, but little is known about the loss of SMARCB1 or SMARCA4 protein expression in this context. Here, we report 2 children in whom malignant supratentorial brain tumors with SMARCB1 deficiency, complex copy number alterations, and somatic <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutations lead to the discovery of pathogenic\/likely pathogenic <jats:italic toggle=\"yes\">TP53<\/jats:italic> variants in the germline. Screening of the molecularneuropathology.org dataset for cases with similar genetic and epigenetic alterations yielded another case with SMARCA4 deficiency in a young adult with Li-Fraumeni syndrome. In conclusion, SMARCB1-deficient or SMARCA4-deficient malignant brain tumors with complex copy number alterations and somatic <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutations in children and young adults may represent the first clinical manifestation of Li-Fraumeni syndrome and should prompt genetic counseling and investigation for <jats:italic toggle=\"yes\">TP53<\/jats:italic> germline status.<\/jats:p>","DOI":"10.1097\/pas.0000000000001905","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T20:04:41Z","timestamp":1650571481000},"page":"1277-1283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome"],"prefix":"10.1097","volume":"46","author":[{"given":"Martin","family":"Hasselblatt","sequence":"first","affiliation":[{"name":"Institute of Neuropathology, University Hospital M\u00fcnster, M\u00fcnster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thomas","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, University Hospital M\u00fcnster, M\u00fcnster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniello","family":"Federico","sequence":"additional","affiliation":[{"name":"Hopp Children\u2019s Cancer Center (KiTZ)"},{"name":"Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Nemes","sequence":"additional","affiliation":[{"name":"Swabian Childrens\u2019 Cancer Center, University Hospital Augsburg and EU-RHAB Registry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal D.","family":"Johann","sequence":"additional","affiliation":[{"name":"Hopp Children\u2019s Cancer Center (KiTZ)"},{"name":"Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)"},{"name":"Swabian Childrens\u2019 Cancer Center, University Hospital Augsburg and EU-RHAB Registry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bison","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, University Hospital Augsburg, Augsburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bens","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Dahlum","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Kordes","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Redlich","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Otto von Guericke University Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lienhard","family":"Lessel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Otto von Guericke University Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian W.","family":"Pajtler","sequence":"additional","affiliation":[{"name":"Hopp Children\u2019s Cancer Center (KiTZ)"},{"name":"Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)"},{"name":"Department of Pediatric Oncology, Hematology, and Immunology, University Hospital Heidelberg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Otto von Guericke University Magdeburg, Magdeburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sch\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf"},{"name":"Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, and Research Institute Children\u2019s Cancer Center Hamburg, Hamburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Nolte","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, RWTH Aachen University Hospital, Aachen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof M.","family":"Kramm","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, University Medical Center G\u00f6ttingen, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hinz","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Sahm","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Giannini","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Penkert","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Kratz","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Pfister","sequence":"additional","affiliation":[{"name":"Hopp Children\u2019s Cancer Center (KiTZ)"},{"name":"Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)"},{"name":"Department of Pediatric Oncology, Hematology, and Immunology, University Hospital Heidelberg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Paulus","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, University Hospital M\u00fcnster, M\u00fcnster"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kool","sequence":"additional","affiliation":[{"name":"Hopp Children\u2019s Cancer Center (KiTZ)"},{"name":"Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)"},{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Fr\u00fchwald","sequence":"additional","affiliation":[{"name":"Swabian Childrens\u2019 Cancer Center, University Hospital Augsburg and EU-RHAB Registry"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/neuonc\/nov264","article-title":"Atypical teratoid\/rhabdoid tumors-current concepts, advances in biology, and potential future therapies","volume":"18","author":"Fr\u00fchwald","year":"2016","journal-title":"Neuro Oncol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3171\/jns.1996.85.1.0056","article-title":"Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood: definition of an entity","volume":"85","author":"Rorke","year":"1996","journal-title":"J Neurosurg"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/bpa.12967","article-title":"Histopathological patterns in atypical teratoid\/rhabdoid tumors are related to molecular subgroup","volume":"31","author":"Zin","year":"2021","journal-title":"Brain Pathol"},{"key":"R4-20250608","first-page":"74","article-title":"Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors","volume":"59","author":"Biegel","year":"1999","journal-title":"Cancer Res"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00000478-200405000-00013","article-title":"Immunohistochemical analysis of hSNF5\/INI1 in pediatric CNS neoplasms","volume":"28","author":"Judkins","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/PAS.0b013e3182196a39","article-title":"Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid\/rhabdoid tumor showing retained SMARCB1 (INI1) expression","volume":"35","author":"Hasselblatt","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/neuonc\/noz235","article-title":"Molecular subgrouping of atypical teratoid\/rhabdoid tumors-a reinvestigation and current consensus","volume":"22","author":"Ho","year":"2020","journal-title":"Neuro Oncol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/PAS.0b013e3182382a3f","article-title":"Atypical teratoid\/rhabdoid tumor arising in a ganglioglioma: genetic characterization","volume":"35","author":"Kleinschmidt-DeMasters","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11060-007-9361-z","article-title":"Atypical teratoid\/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma","volume":"84","author":"Chacko","year":"2007","journal-title":"J Neurooncol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/pbc.26173","article-title":"Atypical teratoid\/rhabdoid tumor arising in a malignant glioma","volume":"64","author":"Bozzai","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","article-title":"Analysis of the Li-Fraumeni spectrum based on an international germline tp53 variant data set: an International Agency for Research on Cancer TP53 Database Analysis","volume":"7","author":"Kratz","year":"2021","journal-title":"JAMA Oncol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-019-02055-3","article-title":"An update on the central nervous system manifestations of Li-Fraumeni syndrome","volume":"139","author":"Orr","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00401-020-02144-8","article-title":"Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features","volume":"139","author":"Sloan","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00401-021-02346-8","article-title":"Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome","volume":"142","author":"Schoof","year":"2021","journal-title":"Acta Neuropathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00401-015-1519-8","article-title":"Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets","volume":"131","author":"Sahm","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/humu.24152","article-title":"Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants","volume":"42","author":"Fortuno","year":"2021","journal-title":"Hum Mutat"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/neuonc\/noaa267","article-title":"The genetic landscape of choroid plexus tumors in children and adults","volume":"23","author":"Thomas","year":"2021","journal-title":"Neuro Oncol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1200\/JCO.2019.37.15_suppl.1517","article-title":"Gliomas in the context of Li-Fraumeni syndrome: an international cohort","volume":"37","author":"Michaeli","year":"2019","journal-title":"J Clin Oncol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAS.0b013e3181ce107b","article-title":"Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6","volume":"34","author":"Kleinschmidt-DeMasters","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/PAS.0000000000001694","article-title":"Atypical teratoid\/rhabdoid tumor (AT\/RT) with molecular features of pleomorphic xanthoastrocytoma","volume":"45","author":"Thomas","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12797","article-title":"Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: a clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC","author":"Hasselblatt","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"a002246","DOI":"10.1101\/mcs.a002246","article-title":"Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT\/RT and her mother with anaplastic astrocytoma","volume":"4","author":"Nordfors","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ajhg.2010.01.013","article-title":"Germline nonsense mutation and somatic inactivation of SMARCA4\/BRG1 in a family with rhabdoid tumor predisposition syndrome","volume":"86","author":"Schneppenheim","year":"2010","journal-title":"Am J Hum Genet"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-014-1323-x","article-title":"SMARCA4-mutated atypical teratoid\/rhabdoid tumors are associated with inherited germline alterations and poor prognosis","volume":"128","author":"Hasselblatt","year":"2014","journal-title":"Acta Neuropathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-020-02250-7","article-title":"Atypical teratoid\/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases","volume":"141","author":"Holdhof","year":"2021","journal-title":"Acta Neuropathol"},{"key":"R27-20250608","first-page":"1","article-title":"Tumors associated with p53 germline mutations: a synopsis of 91 families","volume":"150","author":"Kleihues","year":"1997","journal-title":"Am J Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/01.pas.0000213329.71745.ef","article-title":"Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid\/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype","volume":"30","author":"Haberler","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New brain tumor entities emerge from molecular classification of CNS-PNETs","volume":"164","author":"Sturm","year":"2016","journal-title":"Cell"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/neup.12231","article-title":"Atypical teratoid\/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers","volume":"36","author":"Al-Hussaini","year":"2016","journal-title":"Neuropathology"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/NEN.0b013e31822146ca","article-title":"p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors","volume":"70","author":"Venneti","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1172\/JCI64400","article-title":"A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers","volume":"122","author":"Lee","year":"2012","journal-title":"J Clin Invest"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/gcc.22018","article-title":"High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid\/rhabdoid tumors","volume":"52","author":"Hasselblatt","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/mc.20568","article-title":"Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+\/\u2212);p53(+\/\u2212) mice","volume":"48","author":"DelBove","year":"2009","journal-title":"Mol Carcinog"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1158\/0008-5472.CAN-15-0874","article-title":"Generation of a mouse model of atypical teratoid\/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53","volume":"75","author":"Ng","year":"2015","journal-title":"Cancer Res"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-019-02094-w","article-title":"Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults","volume":"139","author":"Thomas","year":"2020","journal-title":"Acta Neuropathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/PAS.0000000000001520","article-title":"CNS low-grade diffusely infiltrative tumors with INI1 deficiency, possessing a high propensity to progress to secondary INI1-deficient rhabdoid tumors","volume":"44","author":"Nobusawa","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"e12777","DOI":"10.1111\/nan.12777","article-title":"Spatial molecular profiling of a central nervous system low-grade diffusely infiltrative tumor with INI1 deficiency (CNS LGDIT-INI1) featuring a high grade AT\/RT component","volume":"48","author":"Dottermusch","year":"2022","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:04:02Z","timestamp":1749416642000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001905","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,22]]}}}